@article{537d279637a04ff3805694e5915c87cf,
title = "Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia",
author = "Zabriskie, {M. S.} and Eide, {C. A.} and D. Yan and Vellore, {N. A.} and Pomicter, {A. D.} and Savage, {S. L.} and Druker, {B. J.} and Deininger, {M. W.} and T. O'Hare",
note = "Funding Information: Research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health under Award Numbers R01CA178397 (MWD and TO) and P01 CA049639 (MWD), and by a Specialized Center of Research Program Award (SCOR7005 11) from The Leukemia & Lymphoma Society (MWD). We acknowledge support in conjunction with grant P30 CA042014 awarded to the Huntsman Cancer Institute (MWD and TO). BJD is a Howard Hughes Medical Institute investigator and supported by NCI MERIT award R37CA065823. We thank Severine Bateman, a University of Utah ACCESS Program for Women in Science & Mathematics scholar, for technical assistance. Funding Information: Research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health under Award Numbers R01CA178397 (MWD and TO) and P01 CA049639 (MWD), and by a Specialized Center of Research Program.",
year = "2016",
month = jun,
day = "1",
doi = "10.1038/leu.2015.318",
language = "English (US)",
volume = "30",
pages = "1418--1421",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "6",
}